Dr Malcom Barrat-Johnson is the CMO at Albert Labs. Malcolm has over 22 years in the pharmaceutical industry, having worked extensively in senior positions to both Industry and Government. Holding positions at AstraZeneca, Roche, and the UK Medicines Regulatory Agency (MHRA) and European Medicines Evaluation Agency (EMEA). More recently Malcolm, as a Clinical Specialist chaired the European Commission’s Biomedical Research Programme (Horizon 2020). He has also lectured in both Europe and the United States on Medicine & Drug Development.
Explore more info with a membership (any level)
🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)